Read the WSJ article by DeMuth and tell me if there is any argument that perhaps the FDA may go too far in its interpretation of “protecting the public.” Is there a middle ground here? What do you think is the concern of the FDA?

Explain the Court’s ruling and analysis for the approval of drugs for terminally ill patients. Do you agree or disagree? Why?

each question answer one page, reference required